NPPA slashes prices of medicines for TB, cancer, hepatitis B by up to 20% Industry-The Economic Times — September 20, 2017 comments off The move is expected to slash prices of some of these drugs, like Hepatitis B immunoglobulin, by as much as 20%, a senior government told ET on condition of anonymity.
